methylselenic acid has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fesenko, EE; Goltyaev, MV; Varlamova, EG | 1 |
| Chung, AS; Kim, A; Oh, JH; Park, JM | 1 |
2 other study(ies) available for methylselenic acid and Fibrosarcoma
| Article | Year |
|---|---|
Protein Partners of Selenoprotein SELM and the Role of Selenium Compounds in Regulation of Its Expression in Human Cancer Cells.
Topics: Adenocarcinoma; Breast Neoplasms; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Proteins; Organoselenium Compounds; Selenoproteins | 2019 |
Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Topics: Carcinogens; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Precursors; Fibrosarcoma; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Organoselenium Compounds; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured | 2007 |